Latest 10-Q quarterly reports

Titan Acquisition Corp files its Q2 2026 Form 10-Q, detailing its ongoing search for a business combination target and financial status, with a looming liquidation deadline.

Spruce Power Holding Corporation's Q2 2026 10-Q filing reveals substantial doubt about its ability to continue as a going concern due to upcoming debt maturities and negative working capital, despite a return to net income.

AudioEye, Inc. announced its second-quarter 2026 financial results, showcasing a 9% increase in total revenue to $10.7 million and an 11% rise in ARR to $42.3 million, alongside a significant improvement in working capital.

Telomir Pharmaceuticals, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing development of Telomir-Zn, significant net losses, and substantial doubt regarding its ability to continue as a going concern.

AmperCap Acquisition Company reports on its financial condition and operational status for the quarter ended June 30, 2026, detailing its post-IPO activities and trust account management.

Aethlon Medical's Q1 2026 Form 10-Q filing details ongoing clinical development for its Hemopurifier, continued net losses, and a recent capital raise.

Intuitive Machines, Inc. reported a substantial increase in revenues for Q2 2026, largely due to the acquisition of Lanteris, but also posted a significant net loss and increased operating expenses.

Thayer Ventures Acquisition Corporation II filed its Q2 2026 Form 10-Q, detailing its financial position as a SPAC with income generated from its trust account investments.

REalloys Inc. reported a net loss of $36.8 million for Q2 2026, with significant increases in operating expenses driven by stock-based compensation, while also disclosing material weaknesses in internal controls.

PAVmed Inc. filed its Q2 2026 Form 10-Q, detailing continued operational losses, a significant increase in R&D expenses, and substantial doubt regarding its ability to continue as a going concern.

Bridgeline Digital, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting flat total net revenues of $3.9 million and a net loss of $0.5 million.

Z Squared Inc. reported substantial losses from its crypto mining operations in Q2 2026, while simultaneously advancing plans for AI infrastructure development, funded by recent equity issuances.

Estrella Immunopharma's Q2 2026 report highlights significant R&D expenses and a substantial accumulated deficit, leading to a going concern warning despite recent capital raises.

ITHAX Acquisition Corp III, a blank check company, filed its quarterly report for the period ended June 30, 2026, detailing its financial status and operational progress towards a business combination.

MapLight Therapeutics announced increased R&D and G&A expenses for Q2 2026, alongside positive clinical trial updates for ML-007C-MA and ML-004, while also planning a $150M private placement.

Calidi Biotherapeutics, Inc. filed its Q2 2026 Form 10-Q, detailing ongoing operational losses and significant accumulated deficit, leading to substantial doubt about its ability to continue as a going concern.

Camber Energy, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a net loss of $3.47 million for the six months and highlighting substantial going concern risks.

Forefront Tech Holdings Acquisition Corp. reports on its Q2 2026 financial status, detailing the deployment of IPO proceeds and its ongoing search for a business combination target.

PetMed Express reported a significant 19.9% drop in net sales for the second quarter of fiscal year 2026, alongside continued operating losses and a substantial decrease in cash.

Quantum-Si Incorporated reported a significant decline in revenue for the second quarter of 2026, attributed to customer anticipation of its next-generation Proteus platform, which has seen its launch date pushed to Q2 2027, alongside a workforce reduction.

Lument Finance Trust reported a net loss for the second quarter of 2026 and is planning a 1-for-10 reverse stock split to regain NYSE listing compliance.

First Choice Healthcare Solutions, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a substantial net loss and highlighting ongoing concerns about its ability to continue as a going concern.

Xcel Brands, Inc. filed its Form 10-Q for the period ending June 30, 2026, detailing ongoing net losses and significant liquidity concerns, though it also reported on recent debt refinancing and asset sales.

Wen Acquisition Corp filed its Form 10-Q for the quarter ended June 30, 2026, reporting interest income from its trust account and detailing ongoing efforts to identify and complete a business combination.

Live Ventures Incorporated reported a net loss for the quarter ended June 30, 2026, with significant challenges noted at its Precision Metal Works subsidiary, which is in default on its credit facility.

Global Gas Corporation's Q2 2026 report highlights zero revenue, a growing deficit, and substantial doubt about its ability to continue as a going concern, despite ongoing project development efforts.

Atrium Therapeutics, Inc. (Atrium) reported its financial results for the second quarter ended June 30, 2026, highlighting progress in its RNA delivery platform and advancing its lead product candidates for cardiomyopathies.

Concord Acquisition Corp II's Q2 2026 filing reveals continued efforts to secure a business combination, significant accumulated deficit, and a substantial excise tax liability, alongside positive fair value adjustments.

Bogota Financial Corp. reported a significant increase in net income for the second quarter of 2026, driven by higher net interest income and reduced non-interest expenses, despite a decrease in total assets and deposits.

KinderCare Learning Companies reports a net loss of $8.77 million for the quarter and a significant goodwill impairment of $273.5 million, alongside declining enrollment.